AGC Biologics News and Activities

AGC Biologics is owned by AGC.

AGC is one of the...

• Forbes Global 2000 (#1817);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

AGC is a company listed under the stock ticker 5201 (JP).

AGC has a direct presence in 7 countries.

AGC has 6 subsidiaries including AGC Biologics, AGC Biologics Denmark and AGC Glass Europe.

They are in:

• Materials57%
• Biotechnology29%
• Other14%

View the org chart displaying its 21 main executives

Most searched biographies at AGC Biologics

• Alberto Santagostino, Chief Executive Officer and President
• Kasper Møller, Chief Technical Officer and Executive Vice Preside...
• Martin Shawala, Senior Vice President, Quality

Popular executive movements at AGC

• Kunio Watanabe who is General Manager of Research and Development General Division, will become General Manager of Planning on Jan. 1, 2026  (posted on November 11 2025).
• Masahiko Tobari who is General Manager of Information Systems, will become General Manager of Digital Solution on Jan. 1, 2026  (posted on November 11 2025).
• Junya Sone who is Director of Procurement, will be promoted to General Manager of Procurement and Logistics on Jan. 1, 2026  (posted on November 11 2025).

Click here to view some more movements at AGC

Create your alert
to follow the executive moves at AGC Biologics.

AGC has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by AGC Biologics

• Contact Us | AGC Biologics
• Press Releases | AGC Biologics | Tech Transfer
• Contact Us | AGC Biologics
• AGC Biologics to Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance
• AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases
• Contact Us | AGC Biologics
• Contact Us | AGC Biologics
• Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate
• Contact Us | AGC Biologics
• AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance
• View more press releases Close

Social media about AGC Biologics

• AGC Biologics on Wikipedia, Google News & Yahoo Finance
• AGC Biologics on LinkedIn, X (Twitter) & YouTube